# Dapagliflozin After Transcatheter Aortic Valve Implantation

> **NCT04696185** · PHASE4 · COMPLETED · sponsor: **Spanish Society of Cardiology** · enrollment: 1257 (actual)

## Conditions studied

- Aortic Stenosis
- Transcatether Aortic Valve Implantation

## Interventions

- **DRUG:** Dapagliflozin 10 MG

## Key facts

- **NCT ID:** NCT04696185
- **Lead sponsor:** Spanish Society of Cardiology
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-27
- **Primary completion:** 2024-12-29
- **Final completion:** 2024-12-30
- **Target enrollment:** 1257 (ACTUAL)
- **Last updated:** 2025-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04696185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04696185, "Dapagliflozin After Transcatheter Aortic Valve Implantation". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04696185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*